Compare ETON & SCSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ETON | SCSC |
|---|---|---|
| Founded | 2017 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.7M | 1.0B |
| IPO Year | 2018 | 1997 |
| Metric | ETON | SCSC |
|---|---|---|
| Price | $33.98 | $49.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $39.33 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 334.0K | 212.7K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.05 | ★ 2.42 |
| Revenue | $79,950,000.00 | ★ $3,846,260,000.00 |
| Revenue This Year | $40.90 | $2.60 |
| Revenue Next Year | $47.23 | $4.01 |
| P/E Ratio | $669.80 | ★ $20.33 |
| Revenue Growth | ★ 104.94 | 7.79 |
| 52 Week Low | $13.31 | $33.76 |
| 52 Week High | $35.66 | $50.64 |
| Indicator | ETON | SCSC |
|---|---|---|
| Relative Strength Index (RSI) | 64.75 | 62.85 |
| Support Level | $15.77 | $39.44 |
| Resistance Level | $35.66 | $50.64 |
| Average True Range (ATR) | 1.64 | 1.45 |
| MACD | 0.18 | -0.16 |
| Stochastic Oscillator | 84.84 | 71.14 |
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Intelisys & Advisory Segment. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States and Canada, and also has its presence in Brazil, and other countries.